{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:50:35Z","timestamp":1793987435634,"version":"4.8.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["31003A_160147"],"award-info":[{"award-number":["31003A_160147"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["31003A_179381"],"award-info":[{"award-number":["31003A_179381"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.neuropharm.2025.110430","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T12:17:41Z","timestamp":1743077861000},"page":"110430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Chronic social stress induces generalized hyper-sensitivity to aversion: A mouse model with translational validity for understanding and treating negative valence disorders"],"prefix":"10.1016","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4132-4514","authenticated-orcid":false,"given":"Giulia","family":"Poggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Portal\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7296-8166","authenticated-orcid":false,"given":"M\u00e9lisse","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0910-5268","authenticated-orcid":false,"given":"Sophie","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"K\u00fake\u013eov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Sigrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Just","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7811-9795","authenticated-orcid":false,"given":"Bastian","family":"Hengerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5614-4690","authenticated-orcid":false,"given":"Christopher R.","family":"Pryce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110430_bib1","first-page":"470","article-title":"Somatostatin receptor 4 agonism normalizes stress-related excessive amygdala glutamate release and Pavlovian aversion learning and memory in rodents","volume":"2","author":"Adamcyzk","year":"2022","journal-title":"Biol. Psychiatry: Global Open Science"},{"key":"10.1016\/j.neuropharm.2025.110430_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.conb.2008.06.006","article-title":"Fear, faces, and the human amygdala","volume":"18","author":"Adolphs","year":"2008","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110430_bib3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.neuron.2017.12.035","article-title":"Vigilance-associated gamma oscillations coordinate the ensemble activity of basolateral amygdala neurons","volume":"97","author":"Amir","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110430_bib4","first-page":"810C.811","article-title":"Rodent models of depression: learned helplessness induced in mice","volume":"14","author":"Anisman","year":"2001","journal-title":"Curr Prot Neurosci Behavioral Neuroscience, Supplement"},{"key":"10.1016\/j.neuropharm.2025.110430_bib5","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.neuropharm.2025.110430_bib6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuropharm.2014.05.039","article-title":"Mouse social stress induces increased fear conditioning, helplessness and fatigue to physical challenge together with markers of altered immune and dopamine function","volume":"85","author":"Azzinnari","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110430_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s44159-023-00156-1","article-title":"Understanding clinical fear and anxiety through the lens of human fear conditioning","volume":"2","author":"Beckers","year":"2023","journal-title":"Nat Rev Psychol"},{"key":"10.1016\/j.neuropharm.2025.110430_bib89","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.euroneuro.2016.06.009","article-title":"Mouse psychosocial stress reduces motivation and cognitive function in operant reward tests: a model for reward pathology with effects of agomelatine","volume":"26","author":"Bergamini","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110430_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ynstr.2018.01.004","article-title":"Chronic social stress induces peripheral and central immune activation, blunted mesolimbic dopamine function, and reduced reward-directed behaviour","volume":"8","author":"Bergamini","year":"2018","journal-title":"Neurobiology of Stress"},{"key":"10.1016\/j.neuropharm.2025.110430_bib9","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neubiorev.2010.10.016","article-title":"Risk assessment as an evolved threat detection and analysis process","volume":"35","author":"Blanchard","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110430_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.104747","article-title":"Chronic social stress in mice alters energy status including higher glucose need but lower brain utilization","volume":"119","author":"Carneiro-Nascimento","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2025.110430_bib90","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ibneur.2020.11.001","article-title":"Region- and receptor-specific effects of chronic social stress on the central serotonergic system in mice","volume":"10","author":"Carneiro-Nascimento","year":"2021","journal-title":"IBRO Neurosci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110430_bib11","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","article-title":"Antidepressant drugs act by directly binding to TRKB neurotrophin receptors","volume":"184","author":"Casarotto","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2025.110430_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12475","article-title":"Oligodendrocyte gene expression is reduced by and influences effects of chronic social stress in mice","volume":"18","author":"Cathomas","year":"2019","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.neuropharm.2025.110430_bib13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/scan\/nsy032","article-title":"Functional connectivity of the human amygdala in health and in depression","volume":"13","author":"Cheng","year":"2018","journal-title":"Soc Cogn Affect Neurosci"},{"key":"10.1016\/j.neuropharm.2025.110430_bib14","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2025.110430_bib15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1741-7015-11-126","article-title":"Toward the future of psychiatric diagnosis: the seven pillars of RDoC","volume":"11","author":"Cuthbert","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.neuropharm.2025.110430_bib16","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3389\/fgene.2020.00826","article-title":"The emerging role of SGK1 (serum- and glucocorticoid-regulated kinase 1) in major depressive disorder: hypothesis and mechanisms","volume":"11","author":"Dattilo","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.neuropharm.2025.110430_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrn3027","article-title":"Neural mechanisms of the cognitive model of depression","volume":"12","author":"Disner","year":"2011","journal-title":"Nature Rev Neurosci"},{"key":"10.1016\/j.neuropharm.2025.110430_bib18","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.neuron.2014.04.042","article-title":"Amygdala microcircuits controlling learned fear","volume":"82","author":"Duvarci","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110430_bib19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.neuron.2009.05.026","article-title":"Amygdala inhibitory circuits and the control of fear memory","volume":"62","author":"Ehrlich","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110430_bib20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00213-010-1835-6","article-title":"Sustained stress-induced changes in mice as a model for chronic depression","volume":"210","author":"Elizalde","year":"2010","journal-title":"Psychopharmacol. Ser."},{"key":"10.1016\/j.neuropharm.2025.110430_bib21","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1176\/appi.ajp.2007.07030504","article-title":"Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia","volume":"164","author":"Etkin","year":"2007","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110430_bib22","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.neuroscience.2005.09.027","article-title":"Synaptic activation of transient receptor potential channels by metabotropic glutamate receptors in the lateral amygdala","volume":"137","author":"Faber","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110430_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000573","article-title":"Corticolimbic expression of TRPC4 and TRPC5 channels in the rodent brain","volume":"2","author":"Fowler","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110430_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbi.2015.12.020","article-title":"Mouse chronic social stress increases blood and brain kynurenine pathway activity and fear behaviour: both effects are reversed by inhibition of indoleamine 2 3-dioxygenase","volume":"54","author":"Fuertig","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2025.110430_bib25","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00213-019-05448-0","article-title":"Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment","volume":"238","author":"Godlewska","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110430_bib26","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1017\/S0033291712000591","article-title":"Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients","volume":"42","author":"Godlewska","year":"2012","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2025.110430_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2020.09.331","article-title":"P.448 BI 1358894 attenuates cholecystokinin tetrapeptide (CCK-4) induced anxiety and panic symptoms in healthy male volunteers","author":"Goettel","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110430_bib28","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/nprot.2011.361","article-title":"A standardized protocol for repeated social defeat stress in mice","volume":"6","author":"Golden","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2025.110430_bib29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.neuroimage.2016.08.013","article-title":"Chronic psychosocial stress in mice leads to changes in brain functional connectivity and metabolite levels comparable to mouse brain","volume":"142","author":"Grandjean","year":"2016","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2025.110430_bib30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.neuroimage.2017.03.026","article-title":"Dynamic reorganization of intrinsic functional networks in the mouse brain","volume":"152","author":"Grandjean","year":"2017","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2025.110430_bib31","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nature21682","article-title":"Neural ensemble dynamics underlying a long-term associative memory","volume":"543","author":"Grewe","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110430_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuropharm.2016.03.021","article-title":"The need for new approaches in CNS drug discovery: why drugs have failed, and what can be done to improve outcomes","volume":"120","author":"Gribkoff","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110430_bib33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.euroneuro.2022.10.009","article-title":"The effects of transient receptor potential cation channel inhibition by BI 1358894 on cortico-limbic brain reactivity to negative emotional stimuli in major depressive disorder","volume":"65","author":"Grimm","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110430_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41583-019-0221-6","article-title":"The future of rodent models in depression research","author":"Gururajan","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110430_bib35","article-title":"Neuroinflammatory TNFa impairs memory via astrocyte signaling","volume":"110","author":"Habbas","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2025.110430_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.nlm.2014.01.018","article-title":"Chronic stress disrupts fear extinction and enhances amygdala and hippocampal Fos expression in an animal model of post-traumatic stress disorder","volume":"112","author":"Hoffman","year":"2014","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2025.110430_bib37","series-title":"International Statistical Classification of Diseases. 11th Revision","year":"2022"},{"key":"10.1016\/j.neuropharm.2025.110430_bib38","article-title":"Basomedial amygdala activity in mice reflects specific and general aversion uncontrollability","author":"Ineichen","year":"2020","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110430_bib39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.cell.2011.10.009","article-title":"Molecular mechanisms of fear learning and memory","volume":"147","author":"Johansen","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2025.110430_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191225","article-title":"Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice","volume":"13","author":"Just","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110430_bib41","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1126\/science.1214592","article-title":"Fear erasure in mice requires synergy between antidepressant drugs and extinction training","volume":"334","author":"Karpova","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2025.110430_bib42","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.60.8.789","article-title":"Life event dimensions of loss, humiliation, entrapment, and danger in the prediction of onsets of major depression and generalized anxiety","volume":"60","author":"Kendler","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110430_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pnpbp.2018.06.008","article-title":"A review on inflammatory cytokine-induced alterations of the brain as potential neural biomarkers in post-traumatic stress disorder","volume":"91","author":"Kim","year":"2019","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110430_bib44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbr.2016.03.027","article-title":"Loss of the trpc4 gene is associated with a reduction in cocaine self-administration and reduced spontaneous ventral tegmental area dopamine neuronal activity, without deficits in learning for natural rewards","volume":"306","author":"Klipec","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110430_bib45","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1523\/JNEUROSCI.20-10-03843.2000","article-title":"Glucocorticoid negative feedback selectively targets vasopressin transcription in parvocellular neurosecretory neurons","volume":"20","author":"Kov\u00e1cs","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110430_bib46","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/psyp.12518","article-title":"The NIMH research domain criteria initiative: background, issues, and pragmatics","volume":"53","author":"Kozak","year":"2016","journal-title":"Psychophysiology"},{"key":"10.1016\/j.neuropharm.2025.110430_bib47","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cell.2007.09.018","article-title":"Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions","volume":"131","author":"Krishnan","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2025.110430_bib91","first-page":"1","article-title":"Chronic social stress leads to reduced gustatory reward salience and effort valuation in mice","volume":"12","author":"Kukelova","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110430_bib48","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/neurosci3040050","article-title":"Current opinion on the use of c-fos in neuroscience","volume":"3","author":"Lara Aparicio","year":"2022","journal-title":"NeuroSci"},{"key":"10.1016\/j.neuropharm.2025.110430_bib49","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1176\/appi.ajp.2016.16030353","article-title":"Using neuroscience to help understand fear and anxiety: a two-system framework","volume":"173","author":"LeDoux","year":"2016","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110430_bib50","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.biopsych.2013.07.025","article-title":"Generalized anxiety disorder is associated with overgeneralization of classically conditioned fear","volume":"75","author":"Lissek","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110430_bib51","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.brat.2004.10.007","article-title":"Classical fear conditioning in the anxiety disorders: a meta-analysis","volume":"43","author":"Lissek","year":"2005","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.neuropharm.2025.110430_bib52","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1182\/blood-2009-09-246124","article-title":"Selective inhibition of Ido1 effectively regulates mediators of antitumor immunity","volume":"115","author":"Liu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.neuropharm.2025.110430_bib53","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1017\/S0007114517002227","article-title":"The 3Rs in research: a contemporary approach to replacement, reduction and refinement","volume":"120","author":"MacArthur Clark","year":"2018","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.neuropharm.2025.110430_bib54","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.1460-9568.2008.06485.x","article-title":"Pavlovian fear conditioning as a behavioral assay for hippocampus and amygdala function: cautions and caveats","volume":"28","author":"Maren","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110430_bib55","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrn3492","article-title":"The contextual brain: implications for fear conditioning, extinction and psychopathology","volume":"14","author":"Maren","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110430_bib56","article-title":"Individual baseline behavioral traits predict the resilience phenotype after chronic social defeat","volume":"14","author":"Milic","year":"2021","journal-title":"Neurobiol Stress"},{"key":"10.1016\/j.neuropharm.2025.110430_bib57","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1192\/bjp.bp.105.011692","article-title":"Two-week delay in onset of action of antidepressants: new evidence","volume":"188","author":"Mitchell","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110430_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.196","article-title":"Fear learning circuitry is biased toward generalization of fear associations in posttraumatic stress disorder","volume":"5","author":"Morey","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110430_bib59","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/s41386-020-0661-8","article-title":"Neural correlates of conceptual-level fear generalization in posttraumatic stress disorder","volume":"45","author":"Morey","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110430_bib92","doi-asserted-by":"crossref","first-page":"109078","DOI":"10.1016\/j.neuropharm.2022.109078","article-title":"Effects of GPR139 agonism on effort expenditure for food reward in rodent models: Evidence for pro-motivational actions","volume":"213","author":"M\u00fcnster","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110430_bib60","doi-asserted-by":"crossref","DOI":"10.1177\/2398212818804030","article-title":"The research domain criteria framework in drug discovery for neuropsychiatric diseases: focus on negative valence","volume":"2","author":"Nicholson","year":"2018","journal-title":"Brain Neurosci Adv"},{"key":"10.1016\/j.neuropharm.2025.110430_bib61","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biopsych.2010.05.026","article-title":"Learning as a model for neural plasticity in major depression","volume":"68","author":"Nissen","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110430_bib62","series-title":"The Mouse Brain: in Stereotaxic Coordinates","author":"Paxinos","year":"2019"},{"key":"10.1016\/j.neuropharm.2025.110430_bib63","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1124\/mol.111.075341","article-title":"Heteromeric canonical transient receptor potential 1 and 4 channels play a critical role in epileptiform burst firing and seizure-induced neurodegeneration","volume":"81","author":"Phelan","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110430_bib64","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuron.2005.09.025","article-title":"Contributions of the amygdala to emotion processing: from animal models to human behavior","volume":"48","author":"Phelps","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110430_bib65","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrn3339","article-title":"Biological studies of post-traumatic stress disorder","volume":"13","author":"Pitman","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110430_bib66","article-title":"Effects of chronic social stress on oligodendrocyte proliferation-maturation and myelin status in prefrontal cortex and amygdala in adult mice","volume":"18","author":"Poggi","year":"2022","journal-title":"Neurobiol Stress"},{"key":"10.1016\/j.neuropharm.2025.110430_bib67","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.neuropharm.2011.08.012","article-title":"Establishing a learned helplessness effect paradigm in C57BL\/6 mice: behavioural evidence for emotional, motivational and cognitive effects of aversive uncontrollability per se","volume":"62","author":"Pryce","year":"2012","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.neuropharm.2025.110430_bib68","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.pharmthera.2011.06.006","article-title":"Helplessness: a systematic translational review of theory and evidence for its relevance to understanding and treating depression","volume":"132","author":"Pryce","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2025.110430_bib69","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ynstr.2016.10.001","article-title":"Chronic psychosocial stressors in adulthood: studies in mice, rats and tree shrews","volume":"6","author":"Pryce","year":"2017","journal-title":"Neurobiol Stress"},{"key":"10.1016\/j.neuropharm.2025.110430_bib70","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.psyneuen.2010.05.003","article-title":"A translational research framework for enhanced validity of mouse models of psychopathological states in depression","volume":"36","author":"Pryce","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2025.110430_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/h0025984","article-title":"Probability of shock in the presence and absence of CS in fear conditioning","volume":"66","author":"Rescorla","year":"1968","journal-title":"J. Comp. Physiol. Psychol."},{"key":"10.1016\/j.neuropharm.2025.110430_bib72","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1037\/0003-066X.43.3.151","article-title":"Pavlovian conditioning: it's not what you think it is","volume":"43","author":"Rescorla","year":"1988","journal-title":"Am. Psychol."},{"key":"10.1016\/j.neuropharm.2025.110430_bib73","series-title":"Classical Conditioning II: Current Research and Theory","first-page":"64","article-title":"A theory of Pavlovian conditioning: variations in the effectiveness of reinforcement and nonreinforcement","author":"Rescorla","year":"1972"},{"key":"10.1016\/j.neuropharm.2025.110430_bib74","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.cell.2009.03.039","article-title":"Essential role for TRPC5 in amygdala function and fear-related behavior","volume":"137","author":"Riccio","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2025.110430_bib75","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1523\/JNEUROSCI.2274-13.2014","article-title":"Decreased anxiety-like behavior and G\u03b1q\/11-dependent responses in the amygdala of mice lacking TRPC4 channels","volume":"34","author":"Riccio","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110430_bib76","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1111\/bph.13826","article-title":"Cross-species studies of cognition relevant to drug discovery: a translational approach","volume":"174","author":"Robbins","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110430_bib77","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/PSY.0000000000000049","article-title":"Stimulation of systemic low-grade inflammation by psychosocial stress","volume":"76","author":"Rohleder","year":"2014","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.neuropharm.2025.110430_bib78","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/npp.2014.194","article-title":"Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder","volume":"43","author":"Savitz","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110430_bib79","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neuropharm.2015.09.021","article-title":"Somatostatin receptor subtype 4 activation is involved in anxiety and depression-like behavior in mouse models","volume":"101","author":"Scheich","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110430_bib80","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110430_bib81","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.neuron.2008.05.020","article-title":"Emotion, decision making, and the amygdala","volume":"58","author":"Seymour","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110430_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.1008","article-title":"Mouse model of chronic social stress-induced excessive pavlovian aversion learning-memory","volume":"4","author":"Sigrist","year":"2024","journal-title":"Curr Protoc"},{"key":"10.1016\/j.neuropharm.2025.110430_bib83","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00441-002-0656-2","article-title":"Fear memory and the amygdala: insights from a molecular perspective","volume":"310","author":"Stork","year":"2002","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuropharm.2025.110430_bib84","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1017\/S0033291719001387","article-title":"Neural signatures of conditioning, extinction learning, and extinction recall in posttraumatic stress disorder: a meta-analysis of functional magnetic resonance imaging studies","volume":"50","author":"Suarez-Jimenez","year":"2020","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2025.110430_bib85","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: reecnt advances and new questions","volume":"12","author":"Vecsei","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2025.110430_bib86","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature13258","article-title":"Amygdala interneuron subtypes control fear learning through disinhibition","volume":"509","author":"Wolff","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110430_bib93","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s42003-024-06658-9","article-title":"Chronic stress deficits in reward behaviour co-occur with low nucleus accumbens dopamine activity during reward anticipation specifically","volume":"7","author":"Zhang","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.neuropharm.2025.110430_bib87","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.neuron.2019.12.025","article-title":"Amygdala reward neurons form and store fear extinction memory","volume":"105","author":"Zhang","year":"2020","journal-title":"Neuron"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825001364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825001364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T08:33:59Z","timestamp":1778142839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825001364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":92,"alternative-id":["S0028390825001364"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110430","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic social stress induces generalized hyper-sensitivity to aversion: A mouse model with translational validity for understanding and treating negative valence disorders","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110430"}}